US03980N1072
US03980N1072
Ardent Health, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.59B EUR | 1.4B EUR | 1.23B EUR | 1.26B EUR |
Enterprise Value | 3.49B EUR | 2.94B EUR | 2.9B EUR | 2.87B EUR |
Valuation Multiples | ||||
Trailing P/E | 20.18x | 17.85x | 9.12x | 13.36x |
Forward P/E | 9x | -- | -- | -- |
Price to Sales | 0.25x | 0.22x | 0.19x | 0.26x |
Price to Book | 1.19x | 1.03x | 0.92x | 0.98x |
EV/Revenue | 0.55x | 0.46x | 0.45x | 0.59x |
EV/EBITDA | 8.27x | 6.82x | 5.69x | 7.55x |
Price to FCF (P/FCF) | 7.65x | 4.58x | 5.62x | 4.12x |
EV/FCF | 16.78x | 9.64x | 13.31x | 9.37x |
FCF Yield | 13.07% | 21.82% | 17.79% | 24.28% |